Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Mouse Vascular Endothelial Growth Factor D (VEGFD), C-His

Cat. No.AP2C895

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Mouse Vascular Endothelial Growth Factor D (VEGFD), C-His is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 40.9 kDa. The purity is>90%.

Specifications

Type Recombinant Protein
Species Mouse
Expression System Human Cells
Purity >90%
Endotoxin < 1.0 EU/μg
Predicted Molecular Weight 40.9 kDa
Physical State Lyophilized
Formulation 0.01 mol/L PBS (pH 7.2) containing 0.2% (w/v) Procline-300.

Target Information

Mouse Vascular Endothelial Growth Factor D (VEGFD) is involved in angiogenesis and lymphangiogenesis. It plays a role in blood and lymphatic vessel formation, contributing to tissue repair and fluid balance. VEGFD has been implicated in cancer, where it may promote tumor growth and metastasis by forming new vessels. In lymphedema, VEGFD may influence lymphatic vessel function. This protein is a potential target for therapeutic intervention aiming to modulate vessel formation in various diseases.

Protein Mouse Vascular Endothelial Growth Factor D (VEGFD)
Protein Synonym c-Fos-induced growth factor
Gene ID 14205
UniProt ID P97946

Shipping and Storage

This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.
Inquiry Basket